18 December 2024
18 December 2024
The system is designed to be less invasive and can be performed by any trained healthcare worker.
The Leadless CSP feasibility study assesses the performance and safety of the AVEIR CSP system.
The team tested three different PEG-based nanomedicines on blood samples from 15 subjects with leukaemia.
The first-in-human trial is taking place at Na Homolce hospital in Prague, Czechia, and will treat up to 50 patients.
The university plans to use Sectra’s platform to enhance educational resource availability for radiologists in training.
Linus’ Core Cognitive Evaluation tool estimates individuals’ risk of developing dementia and offers clinician guidance.
Olav Bergheim has stepped down from his roles as CEO and chairperson but will continue to serve as an adviser for a year.
Distinguished by its credit card size and cable-free design, the device is claimed to be the first of its kind to be cleared by the US regulator.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
